By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Heat Biologics 

Atlantic Center
119 Washington Avenue, Suite 401
Miami Beach  Florida  33139  U.S.A.
Phone: 305-432-4684 Fax: n/a



Company News
Heat Biologics To Present At The 17th Annual Global Investment Conference 9/2/2015 8:15:55 AM
Heat Biologics Announces Clinical Trial Combining HS-110 And PD-1 Checkpoint Inhibitor In NSCLC 9/1/2015 8:26:58 AM
Heat Biologics Announces Financial Results For The Second Quarter Ended June 30, 2015 8/13/2015 10:04:25 AM
Heat Biologics Announces Promotions Of Taylor Schreiber, M.D., Ph.D., To Chief Scientific Officer, And Melissa Price, Ph.D., To Vice President Of Product Development 7/27/2015 8:17:51 AM
Heat Biologics To Present At The Cantor Fitzgerald Healthcare Conference 7/1/2015 7:59:43 AM
Heat Biologics Announces Development Of Compact, A Next Generation Combination Immunotherapy Platform 6/15/2015 2:01:22 PM
ASCO15: Heat Biologics To Present Interim Immune Response Data From Ongoing Phase II Trial With HS-110 In Advanced NSCLC At ASCO 5/29/2015 8:45:46 AM
Heat Biologics To Present At The Marcum Microcap Conference 5/21/2015 1:30:52 PM
Heat Biologics Announces Financial Results For The First Quarter Ended March 31, 2015 5/14/2015 10:25:46 AM
Heat Biologics Announces Initiation Of Phase Ib Trial Of Viagenpumatucel-L (HS-110) In Non-Small Cell Lung Cancer (NSCLC) 5/11/2015 7:47:23 AM